Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2821

1.

Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.

Carvajal LA, Neriah DB, Senecal A, Benard L, Thiruthuvanathan V, Yatsenko T, Narayanagari SR, Wheat JC, Todorova TI, Mitchell K, Kenworthy C, Guerlavais V, Annis DA, Bartholdy B, Will B, Anampa JD, Mantzaris I, Aivado M, Singer RH, Coleman RA, Verma A, Steidl U.

Sci Transl Med. 2018 Apr 11;10(436). pii: eaao3003. doi: 10.1126/scitranslmed.aao3003.

PMID:
29643228
2.

Modeling the Transition From Decompensated to Pathological Hypertrophy.

Pascual F, Schisler JC, Grevengoed TJ, Willis MS, Coleman RA.

J Am Heart Assoc. 2018 Apr 5;7(8). pii: e008293. doi: 10.1161/JAHA.117.008293.

3.

Bone health during endocrine therapy for cancer.

Rachner TD, Coleman R, Hadji P, Hofbauer LC.

Lancet Diabetes Endocrinol. 2018 Mar 20. pii: S2213-8587(18)30047-0. doi: 10.1016/S2213-8587(18)30047-0. [Epub ahead of print] Review.

PMID:
29572126
4.

The role of tumor microenvironment in resistance to anti-angiogenic therapy.

Ma S, Pradeep S, Hu W, Zhang D, Coleman R, Sood A.

F1000Res. 2018 Mar 15;7:326. doi: 10.12688/f1000research.11771.1. eCollection 2018. Review.

5.

Development and Application of a Sensitive Peptide Reporter to Discover 20S Proteasome Stimulators.

Coleman RA, Trader DJ.

ACS Comb Sci. 2018 Mar 23. doi: 10.1021/acscombsci.7b00193. [Epub ahead of print]

PMID:
29553711
6.

Effects of transportation, transport medium and re-housing on Xenopus laevis (Daudin).

Holmes AM, Emmans CJ, Coleman R, Smith TE, Hosie CA.

Gen Comp Endocrinol. 2018 Mar 12. pii: S0016-6480(17)30859-6. doi: 10.1016/j.ygcen.2018.03.015. [Epub ahead of print]

PMID:
29545087
7.

Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study.

Wilson C, Bell R, Hinsley S, Marshall H, Brown J, Cameron D, Dodwell D, Coleman R.

Eur J Cancer. 2018 May;94:70-78. doi: 10.1016/j.ejca.2018.02.004. Epub 2018 Mar 20.

PMID:
29544162
8.

The little shrimp that could: phylogeography of the circumtropical Stenopus hispidus (Crustacea: Decapoda), reveals divergent Atlantic and Pacific lineages.

Dudoit ', Iacchei M, Coleman RR, Gaither MR, Browne WE, Bowen BW, Toonen RJ.

PeerJ. 2018 Mar 6;6:e4409. doi: 10.7717/peerj.4409. eCollection 2018.

9.

When time affects space: Dispersal ability and extreme weather events determine metacommunity organization in marine sediments.

Corte GN, Gonçalves-Souza T, Checon HH, Siegle E, Coleman RA, Amaral ACZ.

Mar Environ Res. 2018 May;136:139-152. doi: 10.1016/j.marenvres.2018.02.009. Epub 2018 Feb 20.

PMID:
29510875
10.

Ocean acidification but not warming alters sex determination in the Sydney rock oyster, Saccostrea glomerata.

Parker LM, O'Connor WA, Byrne M, Dove M, Coleman RA, Pörtner HO, Scanes E, Virtue P, Gibbs M, Ross PM.

Proc Biol Sci. 2018 Feb 14;285(1872). pii: 20172869. doi: 10.1098/rspb.2017.2869.

PMID:
29445023
11.

Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.

Brown J, Rathbone E, Hinsley S, Gregory W, Gossiel F, Marshall H, Burkinshaw R, Shulver H, Thandar H, Bertelli G, Maccon K, Bowman A, Hanby A, Bell R, Cameron D, Coleman R.

J Natl Cancer Inst. 2018 Feb 7. doi: 10.1093/jnci/djx280. [Epub ahead of print]

PMID:
29425304
12.

A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.

Killion EA, Reeves AR, El Azzouny MA, Yan QW, Surujon D, Griffin JD, Bowman TA, Wang C, Matthan NR, Klett EL, Kong D, Newman JW, Han X, Lee MJ, Coleman RA, Greenberg AS.

Mol Metab. 2018 Mar;9:43-56. doi: 10.1016/j.molmet.2018.01.012. Epub 2018 Jan 31.

13.

Current perspectives on bone metastases in castrate-resistant prostate cancer.

Logothetis C, Morris MJ, Den R, Coleman RE.

Cancer Metastasis Rev. 2018 Mar;37(1):189-196. doi: 10.1007/s10555-017-9719-4. Review.

14.

Cancer Treatment and Bone Health.

Handforth C, D'Oronzo S, Coleman R, Brown J.

Calcif Tissue Int. 2018 Feb;102(2):251-264. doi: 10.1007/s00223-017-0369-x. Epub 2018 Jan 20. Review.

15.

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).

Abraham J, Caldera H, Coleman R, Elias A, Goetz MP, Kittaneh M, Lower E, Mahtani R, Terry Mamounas E, Pegram M, Rugo H, Schwartzberg L, Traina T, Vogel C.

Breast Cancer Res Treat. 2018 May;169(1):1-7. doi: 10.1007/s10549-018-4662-9. Epub 2018 Jan 19. Review.

16.

Quantitation of saxitoxin in human urine using immunocapture extraction and LC-MS.

Bragg WA, Garrett A, Hamelin EI, Coleman RM, Campbell K, Elliott CT, Johnson RC.

Bioanalysis. 2018 Feb;10(4):229-239. doi: 10.4155/bio-2017-0156. Epub 2018 Jan 15.

PMID:
29333869
17.

Artificial barriers prevent genetic recovery of small isolated populations of a low-mobility freshwater fish.

Coleman RA, Gauffre B, Pavlova A, Beheregaray LB, Kearns J, Lyon J, Sasaki M, Leblois R, Sgro C, Sunnucks P.

Heredity (Edinb). 2018 Jan 12. doi: 10.1038/s41437-017-0008-3. [Epub ahead of print]

PMID:
29326479
18.

The Effect of Brief Interventions for Alcohol Among People with Comorbid Mental Health Conditions: A Systematic Review of Randomized Trials and Narrative Synthesis.

Boniface S, Malet-Lambert I, Coleman R, Deluca P, Donoghue K, Drummond C, Khadjesari Z.

Alcohol Alcohol. 2018 May 1;53(3):282-293. doi: 10.1093/alcalc/agx111.

PMID:
29293882
19.

Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.

Richardson DL, Sill MW, Coleman RL, Sood AK, Pearl ML, Kehoe SM, Carney ME, Hanjani P, Van Le L, Zhou XC, Alvarez Secord A, Gray HJ, Landrum LM, Lankes HA, Hu W, Aghajanian C.

JAMA Oncol. 2018 Feb 1;4(2):196-202. doi: 10.1001/jamaoncol.2017.4218.

PMID:
29242937
20.

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.

Huang Y, Hu W, Huang J, Shen F, Sun Y, Ivan C, Pradeep S, Dood R, Haemmerle M, Jiang D, Mangala LS, Noh K, Hansen JM, Dalton HJ, Previs RA, Nagaraja AS, McGuire M, Jennings NB, Broaddus R, Coleman RL, Sood AK.

Mol Cancer Ther. 2018 Feb;17(2):464-473. doi: 10.1158/1535-7163.MCT-17-0006. Epub 2017 Dec 13.

PMID:
29237804
21.

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy.

Lyons YA, Pradeep S, Wu SY, Haemmerle M, Hansen JM, Wagner MJ, Villar-Prados A, Nagaraja AS, Dood RL, Previs RA, Hu W, Zhao Y, Mak DH, Xiao Z, Melendez BD, Lizee GA, Mercado-Uribe I, Baggerly KA, Hwu P, Liu J, Overwijk WW, Coleman RL, Sood AK.

Oncotarget. 2017 Aug 24;8(57):96496-96505. doi: 10.18632/oncotarget.20410. eCollection 2017 Nov 14.

22.

Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.

Noh K, Mangala LS, Han HD, Zhang N, Pradeep S, Wu SY, Ma S, Mora E, Rupaimoole R, Jiang D, Wen Y, Shahzad MMK, Lyons Y, Cho M, Hu W, Nagaraja AS, Haemmerle M, Mak CSL, Chen X, Gharpure KM, Deng H, Xiong W, Kingsley CV, Liu J, Jennings N, Birrer MJ, Bouchard RR, Lopez-Berestein G, Coleman RL, An Z, Sood AK.

Cell Rep. 2017 Dec 5;21(10):2785-2795. doi: 10.1016/j.celrep.2017.11.020.

23.

Increasing habitat complexity on seawalls: Investigating large- and small-scale effects on fish assemblages.

Morris RL, Chapman MG, Firth LB, Coleman RA.

Ecol Evol. 2017 Oct 14;7(22):9567-9579. doi: 10.1002/ece3.3475. eCollection 2017 Nov.

24.

A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer.

Le TN, Harvey RE, Kim CK, Brown J, Coleman RL, Smith JA.

Gynecol Oncol Res Pract. 2017 Nov 14;4:16. doi: 10.1186/s40661-017-0053-x. eCollection 2017.

25.

Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor.

Niu H, Shin H, Gao F, Zhang J, Bahamon B, Danaee H, Melichar B, Schilder RJ, Coleman RL, Falchook G, Adenis A, Behbakht K, DeMichele A, Dees EC, Perez K, Matulonis U, Sawrycki P, Huebner D, Ecsedy J.

EBioMedicine. 2017 Nov;25:50-57. doi: 10.1016/j.ebiom.2017.10.015. Epub 2017 Oct 16.

26.

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.

Anderson RA, Mansi J, Coleman RE, Adamson DJA, Leonard RCF.

Eur J Cancer. 2017 Dec;87:58-64. doi: 10.1016/j.ejca.2017.10.001. Epub 2017 Nov 5.

27.

A Proposed Mathematical Method to Quantify y-Axis Pelvic Rotation on the Anteroposterior Radiograph.

Coleman RR, Lopes MA, Lopes DA.

J Chiropr Med. 2017 Sep;16(3):204-210. doi: 10.1016/j.jcm.2017.08.002. Epub 2017 Sep 28.

28.

Echocardiographic imaging options in ovine research subjects.

Colpitts M, Malinowski M, Phillion R, Coleman R, Mitchell L, Malone A, Eberhart L, Sanders R, Langholz D.

J Vet Cardiol. 2017 Dec;19(6):502-513. doi: 10.1016/j.jvc.2017.09.005. Epub 2017 Oct 31.

PMID:
29097107
29.

Effect of copper on multiple successional stages of a marine fouling assemblage.

McElroy DJ, Hochuli DF, Doblin MA, Murphy RJ, Blackburn RJ, Coleman RA.

Biofouling. 2017 Nov;33(10):904-916. doi: 10.1080/08927014.2017.1384468. Epub 2017 Oct 30.

PMID:
29083229
30.

Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe.

Coleman R, Prins M.

Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00698. No abstract available.

31.

Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).

Mitamura T, Pradeep S, McGuire M, Wu SY, Ma S, Hatakeyama H, Lyons YA, Hisamatsu T, Noh K, Villar-Prados A, Chen X, Ivan C, Rodriguez-Aguayo C, Hu W, Lopez-Berestein G, Coleman RL, Sood AK.

Oncogene. 2018 Feb 8;37(6):722-731. doi: 10.1038/onc.2017.348. Epub 2017 Oct 23.

PMID:
29059175
32.

Feasibility of transthoracic echocardiographic imaging in non-sedated ovine subjects using a commercial restraint device.

Colpitts ME, Phillion RC, Malinowski M, Coleman RA, Mitchell LA, Malone AB, Eberhart LL, Sanders RA, Langholz DE.

Lab Anim. 2018 Apr;52(2):196-199. doi: 10.1177/0023677217736553. Epub 2017 Oct 23.

PMID:
29058999
33.

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease.

Mostafa SA, Coleman RL, Agbaje OF, Gray AM, Holman RR, Bethel MA.

Diabet Med. 2018 Jan;35(1):72-77. doi: 10.1111/dme.13533. Epub 2017 Nov 16.

PMID:
29057545
34.

Renal and colonic potassium transporters in the pregnant rat.

West CA, Welling PA, West DA Jr., Coleman RA, Cheng KY, Chen C, DuBose TD Jr., Verlander JW, Baylis C, Gumz ML.

Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F251-F259. doi: 10.1152/ajprenal.00288.2017. Epub 2017 Oct 18.

PMID:
29046297
35.

Advances in the management of HER2-positive early breast cancer.

Baselga J, Coleman RE, Cortés J, Janni W.

Crit Rev Oncol Hematol. 2017 Nov;119:113-122. doi: 10.1016/j.critrevonc.2017.10.001. Epub 2017 Oct 4. Review.

PMID:
29042085
36.

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.

Coleman R, Hall A, Albanell J, Hanby A, Bell R, Cameron D, Dodwell D, Marshall H, Jean-Mairet J, Tercero JC, Rojo F, Gregory W, Gomis RR.

Lancet Oncol. 2017 Nov;18(11):1543-1552. doi: 10.1016/S1470-2045(17)30603-4. Epub 2017 Oct 13.

PMID:
29037984
37.

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.

Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN, Yang YC, Nyquist MD, Mostaghel E, Hsieh AC, Zhang X, Corey E, Brown LG, Nguyen HM, Pienta K, Ittmann M, Schweizer M, True LD, Wise D, Rennie PS, Vessella RL, Morrissey C, Nelson PS.

Cancer Cell. 2017 Oct 9;32(4):474-489.e6. doi: 10.1016/j.ccell.2017.09.003.

PMID:
29017058
38.

A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor.

Estes C, Sadoughi B, Coleman R, Sarva H, Mauer E, Sulica L.

Laryngoscope. 2018 Feb;128(2):437-446. doi: 10.1002/lary.26911. Epub 2017 Oct 8.

PMID:
28988441
39.

The sport participation legacy of major events in the UK.

Ramchandani G, Coleman R, Christy E.

Health Promot Int. 2017 Sep 15. doi: 10.1093/heapro/dax061. [Epub ahead of print]

PMID:
28973157
40.

The role of biomarkers in the management of bone-homing malignancies.

D'Oronzo S, Brown J, Coleman R.

J Bone Oncol. 2017 Sep 11;9:1-9. doi: 10.1016/j.jbo.2017.09.001. eCollection 2017 Nov. Review.

41.

Health selection into neighborhoods among patients enrolled in a clinical trial.

Arcaya MC, Coleman RL, Razak F, Alva ML, Holman RR.

Prev Med Rep. 2017 Jul 24;8:51-54. doi: 10.1016/j.pmedr.2017.07.003. eCollection 2017 Dec.

42.

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.

Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Sun Y, Theodorakis MJ, Tendera M, Tucker L, Tuomilehto J, Wei Y, Yang W, Wang D, Hu D, Pan C; ACE Study Group.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. doi: 10.1016/S2213-8587(17)30309-1. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917545
43.

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA; ARIEL3 investigators.

Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12.

44.

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.

Oza AM, Tinker AV, Oaknin A, Shapira-Frommer R, McNeish IA, Swisher EM, Ray-Coquard I, Bell-McGuinn K, Coleman RL, O'Malley DM, Leary A, Chen LM, Provencher D, Ma L, Brenton JD, Konecny GE, Castro CM, Giordano H, Maloney L, Goble S, Lin KK, Sun J, Raponi M, Rolfe L, Kristeleit RS.

Gynecol Oncol. 2017 Nov;147(2):267-275. doi: 10.1016/j.ygyno.2017.08.022. Epub 2017 Sep 4.

45.

Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.

Malhotra R, Nguyen HA, Benavente O, Mete M, Howard BV, Mant J, Odden MC, Peralta CA, Cheung AK, Nadkarni GN, Coleman RL, Holman RR, Zanchetti A, Peters R, Beckett N, Staessen JA, Ix JH.

JAMA Intern Med. 2017 Oct 1;177(10):1498-1505. doi: 10.1001/jamainternmed.2017.4377. Review.

46.

Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.

Dalton HJ, Pradeep S, McGuire M, Hailemichael Y, Ma S, Lyons Y, Armaiz-Pena GN, Previs RA, Hansen JM, Rupaimoole R, Gonzalez-Villasana V, Cho MS, Wu SY, Mangala LS, Jennings NB, Hu W, Langley R, Mu H, Andreeff M, Bar-Eli M, Overwijk W, Ram P, Lopez-Berestein G, Coleman RL, Sood AK.

Clin Cancer Res. 2017 Nov 15;23(22):7034-7046. doi: 10.1158/1078-0432.CCR-17-0647. Epub 2017 Aug 29.

PMID:
28855350
47.

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.

Herzog TJ, Ison G, Alvarez RD, Balasubramaniam S, Armstrong DK, Beaver JA, Ellis A, Tang S, Ford P, McKee A, Gershenson DM, Kim G, Monk BJ, Pazdur R, Coleman RL.

Gynecol Oncol. 2017 Oct;147(1):3-10. doi: 10.1016/j.ygyno.2017.08.012. Epub 2017 Aug 24. Review. No abstract available.

PMID:
28844539
48.

Recent advances in lipid droplet biology.

Coleman RA, Hesselink MK.

Biochim Biophys Acta. 2017 Oct;1862(10 Pt B):1129-1130. doi: 10.1016/j.bbalip.2017.08.002. Epub 2017 Aug 16. No abstract available.

PMID:
28821407
49.

A new era of studying p53-mediated transcription activation.

Liu WL, Coleman RA, Singh SK.

Transcription. 2018;9(2):102-107. doi: 10.1080/21541264.2017.1345354. Epub 2017 Oct 4.

PMID:
28795863
50.

Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer.

Fleming ND, Coleman RL, Tung C, Westin SN, Hu W, Sun Y, Bhosale P, Munsell MF, Sood AK.

Gynecol Oncol. 2017 Oct;147(1):41-46. doi: 10.1016/j.ygyno.2017.07.137. Epub 2017 Aug 1.

PMID:
28774461

Supplemental Content

Loading ...
Support Center